CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-29 | Leoni Mollie Chief Medical Officer | Sale | −12,314 | $8.94 | $110K | 158,439 |
| 2025-09-29 | WILSON TROY EDWARD President and CEO | Sale | −36,615 | $8.94 | $327K | 246,853 |
| 2025-09-29 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −4,541 | $8.94 | $41K | 109,829 |
| 2025-09-27 | Powl Brian T. Chief Commercial Officer | Grant or award | +48,900 | 108,567 | ||
| 2025-09-27 | Bair Teresa Brophy Chief Legal Officer | Grant or award 10b5-1 | +48,900 | 156,848 | ||
| 2025-09-27 | FORD KATHLEEN Chief Operating Officer | Grant or award 10b5-1 | −48,900 | 70,267 | ||
| 2025-09-27 | Leoni Mollie Chief Medical Officer | Grant or award | +82,500 | 170,753 | ||
| 2025-09-27 | WILSON TROY EDWARD President and CEO | Grant or award | +182,500 | 283,468 | ||
| 2025-09-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +24,966 | 114,370 | ||
| 2025-09-08 | WILSON TROY EDWARD President & CEO | Purchase | +50,000 | $8.20 | $410K | 100,968 |
| 2025-08-13 | WILSON TROY EDWARD President and CEO | Purchase | +13,494 | $6.64 | $90K | 50,968 |
| 2025-08-12 | WILSON TROY EDWARD President and CEO | Purchase | +36,506 | $5.85 | $214K | 37,474 |
| 2025-06-05 | Collins Helen Louise Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-06-05 | Parks Diane L. Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-06-05 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-06-05 | SCHAFER CAROL Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-06-05 | VASCONCELLES MICHAEL Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-06-05 | Malley Thomas Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-06-05 | Szela Mary T Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-05-19 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −1,559 | $5.96 | $9K | 107,948 |
Page 5 of 9 · 164 trades